Advagene Biopharma Co., Ltd. (TPEX:6709)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
26.50
0.00 (0.00%)
Apr 29, 2026, 12:13 PM CST
51.86%
Market Cap 1.57B
Revenue (ttm) n/a
Net Income (ttm) -68.29M
Shares Out 59.38M
EPS (ttm) -1.15
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,151
Average Volume 67,962
Open 27.00
Previous Close 26.50
Day's Range 25.90 - 27.00
52-Week Range 16.65 - 41.00
Beta 0.85
RSI 42.46
Earnings Date May 14, 2026

About Advagene Biopharma

Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. It engages in the development of nasal spray influenza vaccine; respiratory allergy treatment vaccine, including rhinitis and asthma; COVID-19 immunotherapy; and other vaccines. The company was founded in 2006 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 16
Stock Exchange Taipei Exchange
Ticker Symbol 6709
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.